A cis-acting nucleotide sequence which is capable of rendering the removal of introns from a precursor transcript encoded by a gene, which gene harbors at least one such cis-acting nucleotide sequence, occurring during the production of mRNA of a gene, dependent upon activation of a trans-acting factor. The trans-acting factor is an RNA-activated protein kinase which is capable of phosphorylating the -subunit of eukaryotic initiation factor 2. The trans-acting factor is preferably, the RNA-activated protein kinase (PKR). The cis-acting nucleotide sequence can be derived from the 3 untranslated region of the human tumor necrosis factor gene (TNF-3-UTR) and may comprise the nucleotide sequence as denoted by SEQ ID NO:1 or biologically functional fragments, derivatives, mutants and homologues thereof.

 
Web www.patentalert.com

< Expression of epidermal growth factor in plant seeds

< Use of carboxymethyl cellulose acetate butyrate as a precoat or size for cellulosic man-made fiber boards

> Methods and means for producing efficient silencing construct using recombinational cloning

> One step immunization procedure for inducing a Chlamydia specific immune response

~ 00263